These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35871602)

  • 1. Periodontitis may impair the homeostasis of systemic bone through regulation of gut microbiota in ApoE
    Li L; Wang M; Bao J; Wang N; Huang Y; He S; Chen B; Yan F
    J Clin Periodontol; 2022 Dec; 49(12):1304-1319. PubMed ID: 35871602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porphyromonas gingivalis-derived lysine gingipain enhances osteoclast differentiation induced by tumor necrosis factor-α and interleukin-1β but suppresses that by interleukin-17A: importance of proteolytic degradation of osteoprotegerin by lysine gingipain.
    Akiyama T; Miyamoto Y; Yoshimura K; Yamada A; Takami M; Suzawa T; Hoshino M; Imamura T; Akiyama C; Yasuhara R; Mishima K; Maruyama T; Kohda C; Tanaka K; Potempa J; Yasuda H; Baba K; Kamijo R
    J Biol Chem; 2014 May; 289(22):15621-30. PubMed ID: 24755218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the Effects of Systemically Administered Strontium Ranelate on Alveolar Bone Loss Histomorphometrically and Histopathologically on Experimental Periodontitis in Rats.
    Karakan NC; Akpınar A; Göze F; Poyraz Ö
    J Periodontol; 2017 Feb; 88(2):e24-e31. PubMed ID: 27615270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of toll-like receptor 2 in inflammation and alveolar bone loss in experimental peri-implantitis versus periodontitis.
    Yu X; Hu Y; Freire M; Yu P; Kawai T; Han X
    J Periodontal Res; 2018 Feb; 53(1):98-106. PubMed ID: 28872184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis.
    Crotti T; Smith MD; Hirsch R; Soukoulis S; Weedon H; Capone M; Ahern MJ; Haynes D
    J Periodontal Res; 2003 Aug; 38(4):380-7. PubMed ID: 12828654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis.
    Jin Q; Cirelli JA; Park CH; Sugai JV; Taba M; Kostenuik PJ; Giannobile WV
    J Periodontol; 2007 Jul; 78(7):1300-8. PubMed ID: 17608585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cinnamic acid decreases periodontal inflammation and alveolar bone loss in experimental periodontitis.
    Karatas O; Balci Yuce H; Taskan MM; Gevrek F; Alkan C; Isiker Kara G; Temiz C
    J Periodontal Res; 2020 Oct; 55(5):676-685. PubMed ID: 32335913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut Microbiota May Mediate the Influence of Periodontitis on Prediabetes.
    Li L; Bao J; Chang Y; Wang M; Chen B; Yan F
    J Dent Res; 2021 Nov; 100(12):1387-1396. PubMed ID: 33899584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated microbiome and metabolomics revealed the protective effect of baicalin on alveolar bone inflammatory resorption in aging.
    Hu H; Yao Y; Liu F; Luo L; Liu J; Wang X; Wang Q
    Phytomedicine; 2024 Feb; 124():155233. PubMed ID: 38181526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic administration of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4)-Ig abrogates alveolar bone resorption in induced periodontitis through inhibition of osteoclast differentiation and activation: An experimental investigation.
    Nakane S; Imamura K; Hisanaga R; Ishihara K; Saito A
    J Periodontal Res; 2021 Oct; 56(5):972-981. PubMed ID: 34129238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Berberine Ameliorates Periodontal Bone Loss by Regulating Gut Microbiota.
    Jia X; Jia L; Mo L; Yuan S; Zheng X; He J; Chen V; Guo Q; Zheng L; Yuan Q; Xu X; Zhou X
    J Dent Res; 2019 Jan; 98(1):107-116. PubMed ID: 30199654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis.
    Ozaki Y; Koide M; Furuya Y; Ninomiya T; Yasuda H; Nakamura M; Kobayashi Y; Takahashi N; Yoshinari N; Udagawa N
    PLoS One; 2017; 12(9):e0184904. PubMed ID: 28937990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of luteolin in prevention of periodontal disease in Wistar rats.
    Balci Yuce H; Toker H; Yildirim A; Tekin MB; Gevrek F; Altunbas N
    J Periodontol; 2019 Dec; 90(12):1481-1489. PubMed ID: 31115905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commensal Microbiota Enhance Both Osteoclast and Osteoblast Activities.
    Uchida Y; Irie K; Fukuhara D; Kataoka K; Hattori T; Ono M; Ekuni D; Kubota S; Morita M
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29937485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes Enhances IL-17 Expression and Alters the Oral Microbiome to Increase Its Pathogenicity.
    Xiao E; Mattos M; Vieira GHA; Chen S; Corrêa JD; Wu Y; Albiero ML; Bittinger K; Graves DT
    Cell Host Microbe; 2017 Jul; 22(1):120-128.e4. PubMed ID: 28704648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Boldine inhibits the alveolar bone resorption during ligature-induced periodontitis by modulating the Th17/Treg imbalance.
    Cafferata EA; Castro-Saavedra S; Fuentes-Barros G; Melgar-Rodríguez S; Rivera F; Carvajal P; Hernández M; Cortés BI; Cortez C; Cassels BK; Vernal R
    J Periodontol; 2021 Jan; 92(1):123-136. PubMed ID: 32490537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased serum α-tocopherol acetate mediated by gut microbiota ameliorates alveolar bone loss through the STAT3 signalling pathway in diabetic periodontitis.
    Lu M; Zhang Y; Yuan X; Zhang Y; Zhou M; Zhang T; Song J
    J Clin Periodontol; 2023 Nov; 50(11):1539-1552. PubMed ID: 37596824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dry Extract of Matricaria recutita L. (Chamomile) Prevents Ligature-Induced Alveolar Bone Resorption in Rats via Inhibition of Tumor Necrosis Factor-α and Interleukin-1β.
    Guimarães MV; Melo IM; Adriano Araújo VM; Tenazoa Wong DV; Roriz Fonteles CS; Moreira Leal LK; Ribeiro RA; Lima V
    J Periodontol; 2016 Jun; 87(6):706-15. PubMed ID: 26777767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olmesartan decreases IL-1β and TNF-α levels; downregulates MMP-2, MMP-9, COX-2, and RANKL; and upregulates OPG in experimental periodontitis.
    Araújo AA; Lopes de Souza G; Souza TO; de Castro Brito GA; Sabóia Aragão K; Xavier de Medeiros CA; Lourenço Y; do Socorro Costa Feitosa Alves M; Fernandes de Araújo R
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Oct; 386(10):875-84. PubMed ID: 23775504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoclast differentiation by RANKL and OPG signaling pathways.
    Udagawa N; Koide M; Nakamura M; Nakamichi Y; Yamashita T; Uehara S; Kobayashi Y; Furuya Y; Yasuda H; Fukuda C; Tsuda E
    J Bone Miner Metab; 2021 Jan; 39(1):19-26. PubMed ID: 33079279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.